Teladoc Health (NYSE:TDOC) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Teladoc Health (NYSE:TDOC) released its earnings results on Thursday. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02), Briefing.com reports. The company had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.37) earnings per share.

Teladoc Health Price Performance

NYSE:TDOC traded down $0.13 during trading hours on Friday, reaching $13.20. 4,056,520 shares of the company traded hands, compared to its average volume of 4,752,946. The firm’s 50-day moving average is $15.17 and its 200-day moving average is $17.80. The stock has a market cap of $2.23 billion, a P/E ratio of -9.87 and a beta of 0.94. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47. Teladoc Health has a 1-year low of $12.65 and a 1-year high of $30.41.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, COO Michael Willem Waters sold 4,523 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total transaction of $86,751.14. Following the sale, the chief operating officer now owns 38,570 shares in the company, valued at approximately $739,772.60. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Teladoc Health news, insider Laizer Kornwasser sold 7,882 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total transaction of $151,176.76. Following the transaction, the insider now owns 57,223 shares of the company’s stock, valued at approximately $1,097,537.14. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Michael Willem Waters sold 4,523 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $86,751.14. Following the completion of the transaction, the chief operating officer now directly owns 38,570 shares in the company, valued at $739,772.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 135,441 shares of company stock worth $2,038,251. 1.63% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. DA Davidson lowered their price objective on Teladoc Health from $22.00 to $18.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. Barclays reduced their target price on Teladoc Health from $25.00 to $20.00 and set an “overweight” rating for the company in a report on Friday. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a report on Friday. Royal Bank of Canada reduced their target price on Teladoc Health from $30.00 to $25.00 and set an “outperform” rating for the company in a report on Wednesday, February 21st. Finally, Stifel Nicolaus reduced their target price on Teladoc Health from $21.00 to $16.00 and set a “hold” rating for the company in a report on Friday. Nine analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, Teladoc Health has a consensus rating of “Hold” and a consensus price target of $21.21.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.